Christofer Toumazou

Christofer "Chris" Toumazou is a distinguished British Cypriot electronic engineer serving as the Regius Professor of Engineering at Imperial College London, a prestigious appointment made during the Queen's Diamond Jubilee in 2013. He also holds positions as Chief Scientist of the Institute of Biomedical Engineering and Professor of Circuit Design at Imperial. Beyond academia, Toumazou is an accomplished entrepreneur, having founded Toumaz Holdings Ltd and DNA Electronics Ltd., and co-founding DNAnudge, which developed the groundbreaking CovidNudge point-of-care diagnostic system.

With a research portfolio spanning over 800 publications, Toumazou's work primarily focuses on the intersection of semiconductor technology and biomedical applications. His most significant contribution is the development of ISFET (Ion-Sensitive Field-Effect Transistor) technology for DNA detection, which eliminates the need for optical systems in genetic testing and enables miniaturized, lab-free diagnostic devices. This innovation has been applied across various healthcare domains including pandemic response, cancer diagnostics, and personalized medicine.

Toumazou's publication record shows consistent high-impact output across biomedical engineering, electrical engineering, and applied physics. His recent work (2020-2022) has particularly emphasized point-of-care diagnostics, personalized healthcare systems integrating genetic information with real-time monitoring, and novel approaches to DNA analysis. His research demonstrates a clear trajectory from fundamental circuit design to practical healthcare applications that address significant clinical needs.

• Fellow of the Royal Society (FRS)
• Fellow of the Royal Academy of Engineering (FREng)
• Fellow of the Academy of Medical Sciences (FMedSci)
• Fellow of the Institution of Engineering and Technology (FIET)
• Fellow of the Institute of Electrical and Electronics Engineers (FIEEE)
• Regius Professor of Engineering at Imperial College London

Professor Toumazou maintains an active research program with numerous ongoing projects bridging engineering and medicine. His work continues to focus on developing next-generation diagnostic technologies that integrate semiconductor electronics with biological systems, with particular emphasis on making sophisticated genetic testing accessible at the point of care. Through his academic position and entrepreneurial ventures, he maintains strong connections between fundamental research, commercial development, and clinical implementation of new healthcare technologies.